{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:57:18Z","timestamp":1792547838484,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.atherosclerosis.2024.117519","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T07:49:02Z","timestamp":1710834542000},"page":"117519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Heparanase promotes the onset and progression of atherosclerosis in apolipoprotein E gene knockout mice"],"prefix":"10.1016","volume":"392","author":[{"given":"Tien K.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Paone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy A.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyce J.","family":"Mayfosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Kha","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enoch","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlheinz","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan K.H.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane R.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2072-5968","authenticated-orcid":false,"given":"Mark D.","family":"Hulett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.12998\/wjcc.v3.i4.345","article-title":"Atherosclerosis and the role of immune cells","volume":"3","author":"Ilhan","year":"2015","journal-title":"World J. Clin. Cases"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","article-title":"How the immune system shapes atherosclerosis: roles of innate and adaptive immunity","volume":"22","author":"Roy","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.117519_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1089\/ars.2008.2027","article-title":"Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities","volume":"10","author":"Thomas","year":"2008","journal-title":"Antioxidants Redox Signal."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib5","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis","volume":"84","author":"Stocker","year":"2004","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/CIRCRESAHA.115.306427","article-title":"Adaptive response of T and B cells in atherosclerosis","volume":"118","author":"Ketelhuth","year":"2016","journal-title":"Circ. Res."},{"issue":"7855","key":"10.1016\/j.atherosclerosis.2024.117519_bib7","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117519_bib8","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.atherosclerosis.2024.117519_bib9","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117519_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1096\/fj.04-1970com","article-title":"Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models","volume":"19","author":"Zcharia","year":"2005","journal-title":"Faseb. J."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0002-9440(10)62321-8","article-title":"Heparanase regulates murine hair growth","volume":"166","author":"Zcharia","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117519_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1095\/biolreprod.107.061317","article-title":"Heparanase expression and function during early pregnancy in mice","volume":"77","author":"D'Souza","year":"2007","journal-title":"Biol. Reprod."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/eji.201343645","article-title":"Mice deficient in heparanase exhibit impaired dendritic cell migration and reduced airway inflammation","volume":"44","author":"Poon","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117519_bib14","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1172\/JCI92958","article-title":"NK cell heparanase controls tumor invasion and immune surveillance","volume":"127","author":"Putz","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117519_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12967-020-02624-1","article-title":"Heparanase and the hallmarks of cancer","volume":"18","author":"Jayatilleke","year":"2020","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117519_bib16","doi-asserted-by":"crossref","first-page":"C1184","DOI":"10.1152\/ajpcell.00269.2013","article-title":"Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium","volume":"306","author":"Lever","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117519_bib17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2337\/db11-1024","article-title":"Heparanase is essential for the development of diabetic nephropathy in mice","volume":"61","author":"Gil","year":"2012","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117519_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011171","article-title":"Degradation of glycocalyx and multiple manifestations of endothelial dysfunction coincide in the early phase of endothelial dysfunction before atherosclerotic plaque development in apolipoprotein E\/Low-Density lipoprotein receptor-deficient mice","volume":"8","author":"Bar","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2024.117519_bib19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.atherosclerosis.2016.07.930","article-title":"Endothelial glycocalyx, apoptosis and inflammation in an atherosclerotic mouse model","volume":"252","author":"Cancel","year":"2016","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.117519_bib20","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1161\/01.RES.0000101744.47866.D5","article-title":"Heparan sulfate proteoglycan is a mechanosensor on endothelial cells","volume":"93","author":"Florian","year":"2003","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1172\/JCI119602","article-title":"Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix","volume":"100","author":"Pillarisetti","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib22","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1016\/j.crvasa.2015.08.002","article-title":"Monocyte adhesion to the endothelium is an initial stage of atherosclerosis development","volume":"58","author":"\u010cejkov\u00e1","year":"2016","journal-title":"Cor Vasa"},{"issue":"50","key":"10.1016\/j.atherosclerosis.2024.117519_bib23","doi-asserted-by":"crossref","first-page":"29760","DOI":"10.1074\/jbc.270.50.29760","article-title":"Lysolecithin-induced alteration of subendothelial heparan sulfate proteoglycans increases monocyte binding to matrix","volume":"270","author":"Sivaram","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018370","article-title":"Role of heparanase on hepatic uptake of intestinal derived lipoprotein and fatty streak formation in mice","volume":"6","author":"Planer","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117519_bib25","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00125-011-2110-z","article-title":"Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis","volume":"54","author":"Rao","year":"2011","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117519_bib26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.atherosclerosis.2010.09.003","article-title":"Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine","volume":"213","author":"Baker","year":"2010","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117519_bib27","doi-asserted-by":"crossref","first-page":"e1832","DOI":"10.21769\/BioProtoc.1832","article-title":"Preparation of single cell suspensions from mouse aorta","volume":"6","author":"Hu","year":"2016","journal-title":"Bio-protocol"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2024.117519_bib28","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1161\/CIRCULATIONAHA.105.590018","article-title":"Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress","volume":"113","author":"Cheng","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.117519_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166170","article-title":"VCAM-1 as a predictor biomarker in cardiovascular disease","volume":"1867","author":"Troncoso","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117519_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117519_bib31","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/ATVBAHA.112.254961","article-title":"Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression","volume":"33","author":"Blich","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.117519_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109596","article-title":"Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4","volume":"9","author":"Goodall","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117519_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2012.09.030","article-title":"Increased expression of heparanase in symptomatic carotid atherosclerosis","volume":"226","author":"Osterholm","year":"2013","journal-title":"Atherosclerosis"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2024.117519_bib34","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.3390\/cells11203198","article-title":"Heparanase: a novel therapeutic target for the treatment of atherosclerosis","volume":"11","author":"Nguyen","year":"2022","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117519_bib35","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/ATVBAHA.122.318177","article-title":"Regulated necrosis in atherosclerosis","volume":"42","author":"Puylaert","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.plipres.2011.04.002","article-title":"Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy","volume":"50","author":"McLaren","year":"2011","journal-title":"Prog. Lipid Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117519_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034313","article-title":"Heparanase affects food intake and regulates energy balance in mice","volume":"7","author":"Karlsson-Lindahl","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117519_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/1358863X08094801","article-title":"Collagens in the progression and complications of atherosclerosis","volume":"14","author":"Adiguzel","year":"2009","journal-title":"Vasc. Med."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.117519_bib39","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1161\/01.RES.0000071345.76095.07","article-title":"Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation","volume":"92","author":"Francis","year":"2003","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117519_bib40","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/CIRCRESAHA.108.180695","article-title":"Heparanase alters arterial structure, mechanics, and repair following endovascular stenting in mice","volume":"104","author":"Baker","year":"2009","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117519_bib41","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/oxfordjournals.jbchem.a003182","article-title":"Heparanase and platelet factor-4 induce smooth muscle cell proliferation and migration via bFGF release from the ECM1","volume":"131","author":"Myler","year":"2002","journal-title":"J. Biochem."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117519_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2004.01.045","article-title":"Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries","volume":"175","author":"Kinsella","year":"2004","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.117519_bib43","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1161\/ATVBAHA.113.301743","article-title":"Profiling of atherosclerotic lesions by gene and tissue microarrays reveals PCSK6 as a novel protease in unstable carotid atherosclerosis","volume":"33","author":"Perisic","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117519_bib44","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1042\/CS20180306","article-title":"Atherosclerosis and inflammation: overview and updates","volume":"132","author":"Geovanini","year":"2018","journal-title":"Clin. Sci. (Lond.)"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117519_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2014 an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.117519_bib46","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.RES.0000146672.10582.17","article-title":"Chemokines in the pathogenesis of vascular disease","volume":"95","author":"Charo","year":"2004","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117519_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0065-1281(96)80037-7","article-title":"VCAM-1 expression and network of VCAM-1 positive vascular dendritic cells in advanced atherosclerotic lesions of carotid arteries and aortas","volume":"98","author":"Bobryshev","year":"1996","journal-title":"Acta Histochem."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2024.117519_bib48","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1158\/0008-5472.CAN-18-4058","article-title":"Heparanase accelerates obesity-associated breast cancer progression","volume":"79","author":"Hermano","year":"2019","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041057","article-title":"Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer","volume":"19","author":"Kong","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib50","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1742-1241.2007.01330.x","article-title":"Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis?","volume":"61","author":"Preiss","year":"2007","journal-title":"Int. J. Clin. Pract."},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2024.117519_bib51","first-page":"38","article-title":"Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis","volume":"82","author":"Peter","year":"1999","journal-title":"Thromb. Haemostasis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117519_bib52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.arcmed.2019.05.003","article-title":"Soluble ICAM 1 and VCAM 1 blood levels alert on subclinical atherosclerosis in non smokers with asymptomatic metabolic syndrome","volume":"50","author":"Varona","year":"2019","journal-title":"Arch. Med. Res."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.117519_bib53","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0167-5699(93)90267-O","article-title":"Circulating adhesion molecules in disease","volume":"14","author":"Gearing","year":"1993","journal-title":"Immunol. Today"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117519_bib54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijcard.2003.07.014","article-title":"Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis","volume":"96","author":"G\u00fcray","year":"2004","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117519_bib55","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.bbadis.2017.12.002","article-title":"Heparan sulfate potentiates leukocyte adhesion on cardiac fibroblast by enhancing Vcam-1 and Icam-1 expression","volume":"1864","author":"Olivares-Silva","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib56","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/sj.bjp.0704321","article-title":"The effects of heparin on the adhesion of human peripheral blood mononuclear cells to human stimulated umbilical vein endothelial cells","volume":"134","author":"Smailbegovic","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117519_bib57","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/jnen\/62.7.780","article-title":"Heparan sulfate proteoglycans modulate monocyte migration across cerebral endothelium","volume":"62","author":"Floris","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117519_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1475-2840-12-37","article-title":"Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K\/AKT pathway","volume":"12","author":"Qin","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib59","doi-asserted-by":"crossref","first-page":"e5181","DOI":"10.1371\/journal.pone.0005181","article-title":"Newly generated heparanase knock-out mice unravel Co-regulation of heparanase and matrix metalloproteinases","volume":"4","author":"Zcharia","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117519_bib60","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"48","key":"10.1016\/j.atherosclerosis.2024.117519_bib61","doi-asserted-by":"crossref","first-page":"E7808","DOI":"10.1073\/pnas.1611380113","article-title":"Heparanase is required for activation and function of macrophages","volume":"113","author":"Gutter-Kapon","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.atherosclerosis.2024.117519_bib62","article-title":"Occurrences and functions of Ly6C(hi) and Ly6C(lo) macrophages in Health and disease","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.117519_bib63","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117519_bib64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117519_bib65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1172\/JCI29950","article-title":"Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata","volume":"117","author":"Swirski","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117519_bib66","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.111.061986","article-title":"Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions","volume":"125","author":"Robbins","year":"2012","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2024.117519_bib67","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/CIRCULATIONAHA.108.823740","article-title":"Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia","volume":"119","author":"Wu","year":"2009","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2024.117519_bib68","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/CIRCULATIONAHA.107.745091","article-title":"Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice","volume":"117","author":"Combadi\u00e8re","year":"2008","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.117519_bib69","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1161\/CIRCRESAHA.116.305723","article-title":"Deficiency in lymphotoxin \u03b2 receptor protects from atherosclerosis in apoE-deficient mice","volume":"116","author":"Grandoch","year":"2015","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.117519_bib70","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2843","article-title":"The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis","volume":"18","author":"Schmidt","year":"2012","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.atherosclerosis.2024.117519_bib71","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1111\/bph.15183","article-title":"Inhibition of heparanase protects against pancreatic beta cell death in streptozotocin-induced diabetic mice via reducing intra-islet inflammatory cell infiltration","volume":"177","author":"Song","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.117519_bib72","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/CIRCRESAHA.108.185793","article-title":"CD11c+ dendritic cells maintain antigen processing, presentation capabilities, and CD4+ T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis","volume":"103","author":"Packard","year":"2008","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117519_bib73","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/ATVBAHA.112.251314","article-title":"Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E\u2013deficient mice","volume":"32","author":"MacRitchie","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117519_bib74","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCRESAHA.111.256529","article-title":"Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity","volume":"109","author":"Daissormont","year":"2011","journal-title":"Circ. Res."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2024.117519_bib75","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/CIRCULATIONAHA.111.046755","article-title":"Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis","volume":"125","author":"D\u00f6ring","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib76","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCRESAHA.115.306542","article-title":"Macrophages and dendritic cells: partners in atherogenesis","volume":"118","author":"Cybulsky","year":"2016","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib77","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/ATVBAHA.114.303566","article-title":"Dendritic cells in atherosclerosis","volume":"35","author":"Zernecke","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117519_bib78","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clim.2009.05.006","article-title":"Dendritic cells in atherosclerotic disease","volume":"134","author":"Niessner","year":"2010","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib79","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4049\/jimmunol.167.4.1862","article-title":"Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells","volume":"167","author":"Penna","year":"2001","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.117519_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035602","article-title":"Dissociation between mature phenotype and impaired transmigration in dendritic cells from heparanase-deficient mice","volume":"7","author":"Benhamron","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117519_bib81","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.176.11.6417","article-title":"Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells","volume":"176","author":"Benhamron","year":"2006","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117519_bib82","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41569-019-0326-7","article-title":"Neutrophils as regulators of cardiovascular inflammation","volume":"17","author":"Silvestre-Roig","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117519_bib83","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","article-title":"Neutrophils in chronic inflammatory diseases","volume":"19","author":"Herrero-Cervera","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.117519_bib84","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1096\/fj.14-265447","article-title":"Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation","volume":"29","author":"Stoler-Barak","year":"2015","journal-title":"Faseb. J."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117519_bib85","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.4049\/jimmunol.162.11.6755","article-title":"Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin","volume":"162","author":"Jung","year":"1999","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.117519_bib86","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/ni1233","article-title":"Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses","volume":"6","author":"Wang","year":"2005","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117519_bib87","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2353\/ajpath.2008.080081","article-title":"Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro","volume":"173","author":"Lin","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117519_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002641","article-title":"Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling","volume":"8","author":"Bradley","year":"2012","journal-title":"PLoS Pathog."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117519_bib89","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood-2010-01-266072","article-title":"A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils","volume":"116","author":"Massena","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117519_bib90","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/ATVBAHA.117.309524","article-title":"Consideration of sex differences in design and reporting of experimental arterial pathology studies-statement from ATVB council","volume":"38","author":"Robinet","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T15:58:39Z","timestamp":1716134319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":90,"alternative-id":["S0021915024000790"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117519","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparanase promotes the onset and progression of atherosclerosis in apolipoprotein E gene knockout mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117519"}}